What are the differences between a patent foramen ovale (PFO) and a patent ductus arteriosus (PDA)?

Difference Between Patent Foramen Ovale and Patent Ductus Arteriosus

Patent foramen ovale (PFO) is a persistent opening between the right and left atria that normally closes after birth, while patent ductus arteriosus (PDA) is a persistent vascular connection between the aorta and pulmonary artery that should close shortly after birth. These are fundamentally different anatomical structures with distinct hemodynamic consequences, clinical presentations, and management approaches.

Anatomical Location and Structure

PFO is an interatrial communication at the level of the fossa ovalis, representing a failure of the septum primum to fuse with the septum secundum after birth 1. It occurs in approximately 25-30% of adults and is a normal part of fetal development 2.

PDA is a vascular connection between the descending aorta (just distal to the left subclavian artery) and the proximal left pulmonary artery 3, 4. It represents persistence of the fetal ductus arteriosus, which normally closes within hours to days after birth in term infants 3.

Hemodynamic Differences

PFO Hemodynamics

• Shunt direction: Predominantly left-to-right during normal conditions, but can reverse to right-to-left with increased right atrial pressure (during Valsalva, coughing, or with elevated right heart pressures) 1
• Pressure gradient: Low-pressure shunt at atrial level
• Volume overload: Typically causes no significant volume overload in isolation
• Clinical significance: Primarily important as a conduit for paradoxical embolism when right-to-left shunting occurs 5

PDA Hemodynamics

• Shunt direction: Initially left-to-right (aorta to pulmonary artery) due to higher systemic pressure 3
• Pressure gradient: High-pressure post-tricuspid shunt
• Volume overload: Causes left ventricular volume overload from increased pulmonary blood flow returning to left heart 6, 3
• Pulmonary hypertension risk: Significant risk of developing pulmonary arterial hypertension and eventual Eisenmenger syndrome with shunt reversal in moderate-to-large PDAs 6, 3, 4

Clinical Presentation

PFO

• Usually asymptomatic in most adults
• Cryptogenic stroke in younger patients (age 18-60) without other identifiable cause, due to paradoxical embolism 7, 1
• Transient ischemic attacks from paradoxical emboli
• Decompression sickness in divers (rare indication)
• No continuous murmur on examination

PDA

• Small PDA: Asymptomatic with continuous "machinery" murmur 3
• Moderate PDA: May present with left heart failure (from LV volume overload) or right heart failure (from pulmonary hypertension) 3
• Large PDA: Eisenmenger physiology with differential cyanosis (lower extremities and sometimes left arm cyanotic, right arm pink) due to right-to-left shunting below the ductal insertion 3, 4
• Continuous murmur that disappears when Eisenmenger syndrome develops 3

Diagnostic Approach

PFO Diagnosis

• Transthoracic echocardiography with saline contrast (bubble study) during Valsalva maneuver to detect right-to-left shunting 1
• Transesophageal echocardiography has higher sensitivity and is recommended for younger adults with unexplained cerebrovascular events 1
• Look for microbubbles passing from right to left atrium within 3-5 cardiac cycles 1
• Assess for atrial septal aneurysm (excursion >10mm), which increases embolic risk 7, 1

PDA Diagnosis

• Echocardiography is the key diagnostic tool, showing the ductal connection, degree of LV volume overload, pulmonary artery pressure, and shunt direction 3
• Oxygen saturation measurement in both hands and feet to detect differential cyanosis from right-to-left shunting 4
• Cardiac catheterization when pulmonary hypertension suspected to measure pulmonary vascular resistance 3, 4
• CMR/CT for additional quantification of LV volumes or PA anatomy when needed 3

Management Differences

PFO Management

For cryptogenic stroke patients (age 18-60):

• PFO closure is recommended over antiplatelet therapy alone in carefully selected patients with cryptogenic stroke, particularly those with atrial septal aneurysm or large shunt (>30 microbubbles or >25 microbubbles depending on study) 7, 1
• The 2018 BMJ guideline and 2018 Canadian Stroke Best Practice recommendations support closure based on CLOSE, REDUCE, and RESPECT trials showing NNT of 20-28 to prevent one stroke over 2-5 years 7, 1
• Device closure is the method of choice when technically suitable 1
• Risk of post-procedure atrial fibrillation is 4.6-6.6% (mostly transient) 7

For asymptomatic PFO:

• No intervention recommended; incidental finding in 25% of population 2

PDA Management

Closure indications 3, 4:

• Class I recommendation: Close if left atrial or LV enlargement present with net left-to-right shunt, PA systolic pressure <50% systemic, and PVR <1/3 systemic
• Class IIa recommendation: May consider closure if PA systolic pressure ≥50% systemic and/or PVR ≥1/3 systemic but still with net left-to-right shunt
• Class III (Harm): Do NOT close if net right-to-left shunt with PA pressure >2/3 systemic or PVR >2/3 systemic (Eisenmenger physiology)

Method of closure:

• Device closure is preferred method when technically suitable 3
• Surgical closure may be needed if calcification present in adults 3

Key Clinical Pitfalls

1. Don't confuse PFO with atrial septal defect (ASD): ASDs are true septal defects causing right heart volume overload; PFOs typically don't cause volume overload 2

2. Assess oxygen saturation correctly in PDA: Measure in BOTH hands and feet, as differential cyanosis (pink right arm, cyanotic left arm and legs) indicates Eisenmenger physiology 4

3. Don't close all PFOs: Only close in specific contexts (cryptogenic stroke with high-risk features in patients 18-60 years old) 7, 1

4. Don't close PDA with established Eisenmenger syndrome: This causes harm by eliminating the "pop-off" for the high pulmonary pressures 3, 4

5. PFO diagnosis requires provocative maneuvers: Valsalva during bubble study is essential; resting studies may miss intermittent right-to-left shunting 1